These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 722960)

  • 61. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
    Jüngst D; Brenner G; Pratschke E; Paumgartner G
    J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: a dose-response study.
    Thistle JL; Hofmann AF; Yu PY; Ott B
    Am J Dig Dis; 1977 Jan; 22(1):1-6. PubMed ID: 835542
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of the purified unsaponifiable fraction of soybean in combination with ursodeoxycholic acid on cholesterol saturation of bile and stone dissolution in gallstone patients.
    Kajiyama G; Kawamoto T; Fujiyama M; Maruhashi A; Miyoshi A
    Hiroshima J Med Sci; 1981 Jun; 30(2):71-83. PubMed ID: 7028684
    [No Abstract]   [Full Text] [Related]  

  • 64. Cheno and urso compared and contrasted.
    Dowling RH
    Acta Med Port; 1983 Jan; 4(1):51-62. PubMed ID: 6337454
    [No Abstract]   [Full Text] [Related]  

  • 65. Prediction of the bile acid composition of bile from serum bile acid analysis during gallstone dissolution therapy.
    Whiting MJ; Watts JM
    Gastroenterology; 1980 Feb; 78(2):220-5. PubMed ID: 7350043
    [No Abstract]   [Full Text] [Related]  

  • 66. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The effect of gallstone-dissolving agents on lipid and bile acid metabolism].
    Kajiyama G
    Nihon Naika Gakkai Zasshi; 1984 Jun; 73(6):733-7. PubMed ID: 6491444
    [No Abstract]   [Full Text] [Related]  

  • 68. Gallstone dissolution in vitro by bile acids, heparin, and quanternary amines.
    Lahana DA; Bonorris GG; Schoenfield LJ
    Surg Gynecol Obstet; 1974 May; 138(5):683-5. PubMed ID: 4823370
    [No Abstract]   [Full Text] [Related]  

  • 69. Effectiveness of ursodeoxycholic acid in gallstone therapy.
    Kutz K; Schulte A
    Gastroenterology; 1977 Sep; 73(3):632-3. PubMed ID: 892365
    [No Abstract]   [Full Text] [Related]  

  • 70. Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones.
    Tint GS; Salen G; Colalillo A; Graber D; Verga D; Speck J; Shefer S
    Ann Intern Med; 1982 Sep; 97(3):351-6. PubMed ID: 7051912
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Bile composition and gallstone formation].
    Hong NK
    Zhonghua Wai Ke Za Zhi; 1983 Jun; 21(6):321-5. PubMed ID: 6641423
    [No Abstract]   [Full Text] [Related]  

  • 72. [Treatment of cholesterol gallstones with ursodesoxycholic acid (author's transl)].
    Bernades P; Bertrand L; Bouvry M; Colin R; Geffroy Y; Hecht Y; Klepping C; Lambert R; Levy VG; Michel H; Paliard P; Paris J; Quinton A
    Nouv Presse Med; 1982 Feb; 11(8):587-9. PubMed ID: 7041086
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.
    Hofmann AF; Thistle JL; Klein PD; Szczepanik PA; Yu PY
    JAMA; 1978 Mar; 239(12):1138-44. PubMed ID: 628065
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bile acids in bile during long-term chenodeoxycholic acid treatment.
    Bremmelgaard A; Pedersen L
    Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time.
    Gustafsson U; Wang FH; Axelson M; Kallner A; Sahlin S; Einarsson K
    Eur J Clin Invest; 1997 May; 27(5):387-91. PubMed ID: 9179545
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Studies of bile lipids and bile acids of wild North American black bears in Nova Scotia, showing a high content of ursodeoxycholic acid.
    MacDonald AC; Williams CN
    J Surg Res; 1985 Feb; 38(2):173-9. PubMed ID: 3968875
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Biliary lithiasis in cystic fibrosis. Study of the bile salts in the serum and in the bile in one case (author's transl)].
    Feigelson J; Pécau Y; Bereziat G; Pépin D; Sauvegrain J; Pennaforte F; Roynette A
    Nouv Presse Med; 1979 Oct; 8(38):3029-31. PubMed ID: 534165
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
    Gustafsson U; Sahlin S; Einarsson C
    Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.